Healthcare -
Biotechnology - NASDAQ - US
$ 9.78
-1.71 %
$ 135 M
Market Cap
-195.6
P/E
CSBR - LONG-TERM DEBT
Long-term Debt CSBR - Champions Oncology, Inc.
6.09 M
LAST VALUE
-14.89%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR